Long-term prognosis of children with Down's syndrome and leukaemia: A 34-year nation-wide experience

Journal of Intellectual Disability Research

Volumn 47, Issue 8, 2003, Pages 617-621

  Rajantie, Jukka ^a   Siimes, M A ^b  

^a JORVI HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Down's syndrome; Leukaemia; Prognosis; Treatment; Trisomy 21

Indexed keywords

ANTHRACYCLINE; ANTILEUKEMIC AGENT; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CONVULSION; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DOWN SYNDROME; DRUG EFFICACY; DRUG SPECIFICITY; ESOPHAGITIS; ESOPHAGUS RUPTURE; FEMALE; FINLAND; FREQUENCY ANALYSIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFANT; INTERSTITIAL PNEUMONIA; LEUKEMIA; LONG TERM CARE; MALE; MYCOSIS; MYOCARDIAL DISEASE; PANCYTOPENIA; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SEPTICEMIA; STOMATITIS;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; MALE; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0242525270     PISSN: 09642633     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2788.2003.00477.x     Document Type: Article

References (9)

1. Arenson E. B. & Forbe M. D. (1989) Bone marrow transplantation for acute leukemia and Down syndrome: report of a successful case and results of a national survey. Journal of Pediatrics 114, 69-72.
2. Chessells J. M., Harrison G., Richards S. M., Bailey C. C., Hill F. G. H. & Hann I. M. (2001) Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment. Archives of Diseases of Childhood 85, 321-5.
3. Fong C.-T. & Brodeur G. M. (1987) Down's syndrome and leukemia: epidemiology, genetics, cytogenetics, and mechanisms of leukemogenesis. Cancer Genetics and Cytogenetics 28, 58-76.
4. Garre M. L., Relling M. V., Kalwinsky D., Dodge R., Crom W. R., Abromowitch M., Pui C.-H. & Evans W. E. (1987) Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia. Journal of Pediatrics 111, 606-12.
5. Gustafsson G., Langmark F., Pihkala U., de Verdier B., Heyman M. & Tysell L. (2000) Childhood cancer in the Nordic countries. In: Proceedings of the Annual Meeting of the Nordic Society of Paediatric Haematology and Oncology, Aalborg, May 2000 (ed. Nordic Society of Paediatric Haematology and Oncology), pp. 87-117. Nordic Society of Paediatric Haematology and Oncology, Aalborg.
6. Kojima S., Matsuyama T., Sato T., Horibe K., Konishi S., Tsuchida M., Hayashi Y., Kigasawa H., Akiyama Y., Okamura J., Nakahata T., Bessho F., Eguchi M., Nakazawa S. & Ueda R. (1990) Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction. Blood 76, 2348-53.
7. Lie S. O., Jonmundsson G., Mellander L., Siimes M. A., Yssing M. & Gustafsson G. (1996) A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. British Journal of Haematology 94, 82-8.
8. Robison L. L., Nesbit M. E., Sather H. N., Shadidi C. L. N., Kennedy A. & Hammond D. (1984) Down syndrome and acute leukemia in children: a 10-year retrospective survey from Children's Cancer Study Group. Journal of Pediatrics 105, 235-42.
9. Zipursky A., Poon A. & Doyle J. (1992) Leukemia in Down syndrome: a review. Pediatric Hematology and Oncology 9, 139-49.